A bright fluorescent signal throughout an entire mammary tumor was indicative that the MMTV-Flp transgene was active and that the recombined Rosa26CAG-FSF-CreERT2 was functional in ERBB2/neu-expressing mammary tumor cells in vivo (Fig. 3C, upper panels). Here, ERBB2 is linked to breast cancer.